More Veterinary Success Seen With Adult Stem Cells
Once again, the successful use of autologous adult stem cells for the treatment of animals is in the news.
August 10, 2009
Once again, the successful use of autologous adult stem cells for the treatment of animals is in the news.
Once again, autologous adult stem cell therapy is successfully used to treat man’s best friend.
Biotech giant Novartis agrees to pay $4 million to Opexa Therapeutics for its proprietary adult stem cell technology.
Scientists apply principles of proteomics to embryonic stem cells in order to learn more about cellular differentiation.
The pharmaceutical company Athersys Inc. has announced that it is seeking commercial partners for the development and testing of its stem cell and drug therapies.
The biotech company Genzyme has received approval from the European Commission for the use of its product Mozobil in the treatment of patients with lymphoma and multiple myeloma.